Closed consultation

Consultation on the International Council for Harmonisation (ICH) M14

From:
Medicines and Healthcare products Regulatory Agency
Published
29 August 2024

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

Consultation on the ICH E2D(R1) guidelines on General principles on plan, design, and analysis of pharmacoepidemiological studies that utilise real-world data for safety assessment of medicines.

This consultation ran from
to

Consultation description

The Medicines and Healthcare products Regulatory Agency (MHRA) became a full member of International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) in May 2022 and is consulting with UK stakeholders and ICH members on the ICH E2D(R1) guideline on General principles on plan, design, and analysis of pharmacoepidemiological studies that utilise real-world data for safety assessment of medicines.

Documents

Consultation on the International Council for Harmonisation (ICH) M14

HTML

Updates to this page

Published 29 August 2024

Sign up for emails or print this page